Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9

Molecular Pharmacology

Volumn 82, Issue 4, 2012, Pages 614-622

  Omanakuttan, Athira ^a   Nambiar, Jyotsna ^a   Harris, Rodney M ^b   Bose, Chinchu ^a   Pandurangan, Nanjan ^a   Varghese, Rebu K ^a   Kumar, Geetha B ^a   Tainer, John A ^c,d   Banerji, Asoke ^a   Perry, J Jefferson P ^a,c   Nair, Bipin G ^a  

^a AMRITA UNIVERSITY   (India)

^b 1060 Discovery Engineering   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANACARDIC ACID; CARBOXYLIC ACID; CARDANOLIDE; GELATINASE A; GELATINASE B; GLUTAMIC ACID; SALICYLIC ACID; ZINC ION;

ANIMAL CELL; ARTICLE; CATALYSIS; CYTOTOXICITY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; FIBROBLAST; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN BOND; MOLECULAR DOCKING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTON NUCLEAR MAGNETIC RESONANCE; ZYMOGRAPHY;

3T3-L1 CELLS; ANACARDIC ACIDS; ANACARDIUM; ANIMALS; CATALYSIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE; MOLECULAR DOCKING SIMULATION; PLANT EXTRACTS;

EID: 84866853936     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.079020     Document Type: Article

References (56)

1. Arun B and Goss P (2004) The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol 31:22-29. (Pubitemid 38879411)
2. Balasubramanyam K, Swaminathan V, Ranganathan A, and Kundu TK (2003) Small molecule modulators of histone acetyltransferase p300. J Biol Chem 278:19134-19140. (Pubitemid 36799302)
3. Begum P, Hashidoko Y, Islam MT, Ogawa Y, and Tahara S (2002) Zoosporicidal activities of anacardic acids against Aphanomyces cochlioides. Z Naturforsch C 57:874-882. (Pubitemid 35273791)
4. Berton A, Rigot V, Huet E, Decarme M, Eeckhout Y, Patthy L, Godeau G, Hornebeck W, Bellon G, and Emonard H (2001) Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids. J Biol Chem 276:20458-20465.
5. Brooks PC, Strömblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, and Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85:683-693. (Pubitemid 26181048)
6. Dhanaraj V, Williams MG, Ye QZ, Molina F, Johnson LL, Ortwine DF, Pavlovsky A, Rubin JR, Skeean RW, White AD, et al. (1999) X-ray structure of gelatinase A catalytic domain complexed with a hydroxamate inhibitor. Croat Chem Acta 72:zpg575-591.
7. Eliseeva ED, Valkov V, Jung M, and Jung MO (2007) Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 6:2391-2398. (Pubitemid 47480404)
8. Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H, Kimura K, Sodeoka M, and Yoshida M (2009) Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 16:133-140.
9. Gellerman JL, Walsh NJ, Werner NK, and Schlenk H (1969) Antimicrobial effects of anacardiac acids. Can J Microbiol 15:1219-1223.
10. Grazzini R, Hesk D, Heininger E, Hildenbrandt G, Reddy CC, Cox-Foster D, Medford J, Craig R, and Mumma RO (1991) Inhibition of lipoxygenase and prostaglandin endoperoxide synthase by anacardic acids. Biochem Biophys Res Commun 176:775-780.
11. Green IR, Tocoli FE, Lee SH, Nihei K, and Kubo I (2007) Molecular design of anti-MRSA agents based on the anacardic acid scaffold. Bioorg Med Chem 15:6236-6241. (Pubitemid 47088953)
12. Green IR, Tocoli FE, Lee SH, Nihei K, and Kubo I (2008) Design and evaluation of anacardic acid derivatives as anticavity agents. Eur J Med Chem 43:1315-1320. (Pubitemid 351734556)
13. Ha TJ and Kubo I (2005) Lipoxygenase inhibitory activity of anacardic acids. J Agric Food Chem 53:4350-4354. (Pubitemid 40855456)
14. Hanessian S, Moitessier N, and Therrien E (2001) A comparative docking study and the design of potentially selective MMP inhibitors. J Comput Aided Mol Des 15:873-881. (Pubitemid 34218291)
15. Harris R, Olson AJ, and Goodsell DS (2008) Automated prediction of ligand-binding sites in proteins. Proteins 70:1506-1517. (Pubitemid 351304108)
16. Himejima M and Kubo IJ (1991) Antibacterial agents from the cashew Anacardium occidentale (Anacardiaceae) nut shell oil. Agric Food Chem 39:418-421.
17. Jezierska A and Motyl T (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit 15:RA32-RA40.
18. Kanojia RM, Murray W, Bernstein J, Fernandez J, Foleno BD, Krause H, Lawrence L, Webb G, and Barrett JF (1999) 6-Oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systems. Bioorg Med Chem Lett 9:2947-2952. (Pubitemid 29499929)
19. Kim MK, Shin JM, Eun HC, and Chung JH (2009) The role of p300 histone acetyltransferase in UV-induced histone modifications and MMP-1 gene transcription. PLoS One 4:e4864.
20. Kishore AH, Vedamurthy BM, Mantelingu K, Agrawal S, Reddy BA, Roy S, Rangappa KS, and Kundu TK (2008) Specific small-molecule activator of aurora kinase A induces autophosphorylation in a cell-free system. J Med Chem 51:792-797. (Pubitemid 351304688)
21. Knight CG, Willenbrock F, and Murphy G (1992) A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 296:263-266.
22. Kubo I, Kinst-Hori I, and Yokokawa Y (1994a) Tyrosinase inhibitors from Anacardium occidentale fruits. J Nat Prod 57:545-551. (Pubitemid 24152917)
23. Kubo I, Masuoka N, Ha TJ, and Tsujimoto K (2006) Antioxidant activity of anacardic acids. Food Chem 99:555-562.
24. Kubo I, Muroi H, and Kubo A (1994b) Naturally occurring antiacne agents. J Nat Prod 57:9-17. (Pubitemid 24076889)
25. Kubo I, Nihei K, and Tsujimoto K (2003) Antibacterial action of anacardic acids against methicillin resistant Staphylococcus aureus (MRSA). J Agric Food Chem 51:7624-7628.
26. Kubo J, Lee JR, and Kubo I (1999) Anti-Helicobacter pylori agents from the cashew apple. J Agric Food Chem 47:533-537. (Pubitemid 29185220)
27. Langenbach R, Loftin CD, Lee C, and Tiano H (1999) Cyclooxygenase- deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann NY Acad Sci 889:52-61. (Pubitemid 30040425)
28. Lia NG, Shib ZH, Tang YP, and Duan JA (2009) Selective matrix metalloproteinase inhibitors for cancer. Curr Med Chem 16:3805-3827.
29. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, and Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67-68. (Pubitemid 10098769)
30. Lovejoy B, Welch AR, Carr S, Luong C, Broka C, Hendricks RT, Campbell JA, Walker KA, Martin R, Van Wart H, et al. (1999) Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Nat Struct Biol 6:217-221. (Pubitemid 29107223)
31. Mannello F (2006) Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon? Recent Pat Anticancer Drug Discov 1:91-103.
32. Maskos K and Bode W (2003) Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Mol Biotechnol 25:241-266. (Pubitemid 37410016)
33. Masuoka N and Kubo I (2004) Characterization of xanthine oxidase inhibition by anacardic acids. Biochim Biophys Acta 1688:245-249. (Pubitemid 38438528)
34. Mendes NM, de Oliveira AB, Guimarães JE, Pereira JP, and Katz N (1990) Molluscacide activity of a mixture of 6-n-alkyl salicylic acids (anacardic acid) and 2 of its complexes with copper (II) and lead (II). Rev Soc Bras Med Trop 23:217-224.
35. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, and Massagué J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518-524. (Pubitemid 41112921)
36. Morais TC, Pinto NB, Carvalho KM, Rios JB, Ricardo NM, Trevisan MT, Rao VS, and Santos FA (2010) Protective effect of anacardic acids from cashew (Anacardium occidentale) on ethanol-induced gastric damage in mice. Chem Biol Interact 183: 264-269.
37. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, and Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639-1662. (Pubitemid 128590223)
38. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
39. Muroi H and Kubo I (1993) Structure-antibacterial activity relationships of anacardic acids. J Agric Food Chem 41:1780-1783.
40. Muroi H and Kubo I (1996) Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin- resistant Staphylococcus aureus. J Appl Bacteriol 80:387-394.
41. Nagase H and Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494. (Pubitemid 129519680)
42. Paramashivappa R, Kumar PP, Vithayathil PJ, and Rao AS (2001) Novel method for isolation of major phenolic constituents from cashew (Anacardium occidentale L.) nut shell liquid. J Agric Food Chem 49:2548-2551. (Pubitemid 32843289)
43. Pereira JM, Severino RP, Vieira PC, Fernandes JB, da Silva MF, Zottis A, Andricopulo AD, Oliva G, and Corrêa AG (2008) Anacardic acid derivatives as inhibitors of glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi. Bioorg Med Chem 16:8889-8895.
44. Perry JJ, Harris RM, Moiani D, Olson AJ, and Tainer JA (2009) p38α MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses. J Mol Biol 391:1-11.
45. Philip JY, Da Cruz Francisco J, Dey ES, Buchweishaija J, Mkayula LL, and Ye L (2008) Isolation of anacardic acid from natural cashew nut shell liquid (CNSL) using supercritical carbon dioxide. J Agric Food Chem 56:9350-9354.
46. Ratnikov BI, Deryugina EI, and Strongin AY (2002) Gelatin zymography and substrate cleavage assays of matrix metalloproteinase-2 in breast carcinoma cells overexpressing membrane type-1 matrix metalloproteinase. Lab Invest 82:1583-1590. (Pubitemid 35332917)
47. Schultz DJ, Wickramasinghe NS, Ivanova MM, Isaacs SM, Dougherty SM, Imbert- Fernandez Y, Cunningham AR, Chen C, and Klinge CM (2010) Anacardic acid inhibits estrogen receptor α-DNA binding and reduces target gene transcription and breast cancer cell proliferation. Mol Cancer Ther 9:594-605.
48. Silva MS, De Lima SG, Oliveira EH, Lopes JA, Chaves MH, Reis FA, Citó AM (2008) Anacardic acid derivatives from Brazilian propolis and their antibacterial activity. Elect Quim 33:53-58.
49. Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448-464.
50. Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M, and Aggarwal BB (2008) Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis. Blood 111:4880-4891.
51. Swamy BN, Suma TK, Rao GV, and Reddy GC (2007) Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis. Eur J Med Chem 42:420-424. (Pubitemid 46349365)
52. Tochowicz A, Maskos K, Huber R, Oltenfreiter R, Dive V, Yiotakis A, Zanda M, Pourmotabbed T, Bode W, and Goettig P (2007) Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity. J Mol Biol 371:989-1006. (Pubitemid 47411454)
53. Trevisan MT, Pfundstein B, Haubner R, Würtele G, Spiegelhalder B, Bartsch H, and Owen RW (2006) Characterization of alkyl phenols in cashew (Anacardium occidentale) products and assay of their antioxidant capacity. Food Chem Toxicol 44:188-197. (Pubitemid 41773813)
54. Vijayababu MR, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G, and Arunakaran J (2006) Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 287:109-116. (Pubitemid 44057398)
55. Vu TH and Werb Z (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14:2123-2133.
56. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, and Goldberg GI (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221. (Pubitemid 19255553)